PUBLIC CONTRACT · 2012
61002713 - Medicamentos antineoplásicos e imunomodulares
- Contract value
- €460,047.89
- Signed on
- 11 December 2012
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 726370PUBLISHED SUBJECT
Aquisição de 756 cápsulas de Lenalidomida 10 mg, 378 cápsulas de Lenalidomida 15 mg, 756 cápsulas de Lenalidomida 25 mg e 588 cápsulas de Talidomida 50 mg
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Faro, Portimão
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Celgene, Sociedade Unipessoal, Lda. · Tax ID 507791690
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €460,047.89
- Procedure base price
- €897,110.28
- Total effective price
- €117,286.63
- Publication date
- 22 February 2013
- Award date
- 10 October 2012
- Signing date
- 11 December 2012
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33652000-5 - Antineoplásicos e imunomoduladores
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 581486
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.